| Dr Frank Robert Cobarrubia, DPM | |
|
1510 Sw Nancy Way Ste 2, Bend, OR 97702-3256 | |
| (541) 385-7129 | |
| (541) 385-7138 |
| Full Name | Dr Frank Robert Cobarrubia |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 31 Years |
| Location | 1510 Sw Nancy Way Ste 2, Bend, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477537710 | NPI | - | NPPES |
| 20-2456582 | Other | OR | TAX ID |
| 228938 | Medicaid | OR | |
| 865318006 | Other | OR | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | DP000331 (Oregon) | Secondary |
| 213E00000X | Podiatrist | DP000331 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Footcare Llc | 7113968256 | 4 |
News Archive
A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion.
The National Radiation Oncology Registry (NROR) pilot program will serve as the basis for the creation of a nationwide electronic registry to capture reliable, population-based information on radiation treatment delivery and health outcomes and will be supported by an innovative information technology (IT) infrastructure that will maximize efficiency through the automated collection and electronic transfer of data, according to research presented at the American Society for Clinical Oncology (ASCO) Quality Care Symposium.
Long-term follow up with heart bypass patients treated in Veterans Affairs hospitals shows that 85 percent of left internal mammary artery grafts and 61 percent of vein grafts remain open (patent) after 10 years, and that these grafts are more likely to offer long-term success when they are attached to larger arteries on the heart, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, announced updated data from its Phase 2 clinical trial of NeuVax at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 3 days ago
| Provider Name | Northwest Footcare Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275545311 PECOS PAC ID: 7113968256 Enrollment ID: O20050518001004 |
News Archive
A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion.
The National Radiation Oncology Registry (NROR) pilot program will serve as the basis for the creation of a nationwide electronic registry to capture reliable, population-based information on radiation treatment delivery and health outcomes and will be supported by an innovative information technology (IT) infrastructure that will maximize efficiency through the automated collection and electronic transfer of data, according to research presented at the American Society for Clinical Oncology (ASCO) Quality Care Symposium.
Long-term follow up with heart bypass patients treated in Veterans Affairs hospitals shows that 85 percent of left internal mammary artery grafts and 61 percent of vein grafts remain open (patent) after 10 years, and that these grafts are more likely to offer long-term success when they are attached to larger arteries on the heart, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, announced updated data from its Phase 2 clinical trial of NeuVax at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Frank Robert Cobarrubia, DPM 1510 Sw Nancy Way Ste 2, Bend, OR 97702-3256 Ph: (541) 385-7129 | Dr Frank Robert Cobarrubia, DPM 1510 Sw Nancy Way Ste 2, Bend, OR 97702-3256 Ph: (541) 385-7129 |
News Archive
A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion.
The National Radiation Oncology Registry (NROR) pilot program will serve as the basis for the creation of a nationwide electronic registry to capture reliable, population-based information on radiation treatment delivery and health outcomes and will be supported by an innovative information technology (IT) infrastructure that will maximize efficiency through the automated collection and electronic transfer of data, according to research presented at the American Society for Clinical Oncology (ASCO) Quality Care Symposium.
Long-term follow up with heart bypass patients treated in Veterans Affairs hospitals shows that 85 percent of left internal mammary artery grafts and 61 percent of vein grafts remain open (patent) after 10 years, and that these grafts are more likely to offer long-term success when they are attached to larger arteries on the heart, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, announced updated data from its Phase 2 clinical trial of NeuVax at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 3 days ago
Dr. Amanda Westfall Mccarty, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1693 Sw Chandler Ave, Suite 280, Bend, OR 97702 Phone: 541-385-7129 Fax: 541-385-7138 | |
Northwest Footcare, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 1693 Sw Chandler Ave, Ste 280, Bend, OR 97702 Phone: 541-385-7129 Fax: 541-385-7138 | |
Antonia Lynn Mcclune, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1501 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-4900 | |
Dr. Laura Schweger Savage, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1506 Ne Williamson Blvd, Bend, OR 97701 Phone: 541-383-3668 Fax: 541-383-4546 | |
Tajyant Nat Chotechuang, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1510 Sw Nancy Way Ste 2, Bend, OR 97702 Phone: 541-385-7129 Fax: 541-385-7138 | |
Bryan Wilhelm, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1510 Sw Nancy Way Ste 2, Bend, OR 97702 Phone: 541-385-7129 Fax: 541-385-7138 |